IDEX Reports Second Quarter EPS of 88 Cents and Raises Full Year EPS Guidance to $3.50 – $3.55

LAKE FOREST, Ill.--()--IDEX Corporation (NYSE: IEX) today announced its financial results for the three month period ended June 30, 2014.

Second Quarter 2014 Highlights

  • Orders increased 9 percent, 7 percent organically
  • Sales increased 5 percent, 4 percent organically
  • Operating margin of 20.5 percent was up 130 basis points from the prior year
  • EPS of 88 cents was 16 percent higher than prior year EPS of 76 cents
  • Acquired Aegis Flow Technologies

Second Quarter 2014

Orders in the quarter of $551 million were up 9 percent (+7 percent organic and +2 percent foreign currency translation) compared with the prior year period and sales of $547 million were up 5 percent (+4 percent organic and +1 percent foreign currency translation) compared with last year.

Second quarter 2014 gross margin of 44.1 percent was up 110 basis points from the prior year period, while operating income of $112 million was up 13 percent from the prior year. This resulted in an operating margin of 20.5 percent, up 130 basis points from prior year operating margin, primarily due to volume leverage and productivity.

Second quarter net income was $72 million, an increase of 15 percent from the prior year period. Second quarter earnings per share were 88 cents, an increase of 12 cents, or 16 percent, from the prior year. EBITDA of $131 million, which was a 10 percent increase from the prior year, was 24 percent of sales and covered interest expense by over 12 times, while free cash flow of $80 million was over 110 percent of net income.

The Company completed the repurchase of 602 thousand shares of common stock for $46 million in the quarter. Year-to-date, the Company has repurchased 1.2 million shares of common stock for $86 million.

“IDEX completed the first half of 2014 with another solid quarter and good momentum for the second half of the year. We have a clear focus to invest in organic growth, while achieving productivity gains. These investments require a greater use of free cash flow, but provide a base for long-term organic growth. The focus on various organic initiatives and core product line strategies is yielding benefits and, as a result, organic revenue growth has accelerated to 6 percent in the first-half of 2014.

We are focused on total shareholder return by increasing organic growth and maintaining a disciplined approach to acquisitions, shareholder dividends and share repurchases. In April, we successfully completed the acquisition of Aegis Flow Technologies (“Aegis”), a leader in specialty chemical processing valves. Aegis will operate in our Chemical, Food & Process platform and expand our presence in the region around the Gulf of Mexico, serving the chemical, petro-chemical, and chlor-alkali industries. We continue to actively pursue multiple acquisition opportunities in an increasingly active M&A environment. We also continue to execute our share repurchase and shareholder dividend programs, which we expect to remain unchanged in the second half of 2014.

Geographically, we see stability in North America and Europe, and continued volatility in Asia. Additionally, we see sales growth in the second half for the FMT and HST segments improving over the first half of the year. Based on these combined factors, we now expect to deliver full-year 2014 organic growth of 5 to 6 percent with operating margins greater than 20 percent. We project third quarter EPS in the range of 83 to 85 cents, and we are increasing our full year 2014 EPS guidance to $3.50 to $3.55.”

Andrew K. Silvernail
Chairman and Chief Executive Officer

Second Quarter 2014 Business Highlights

Fluid & Metering Technologies

  • Sales in the second quarter of $226 million reflected a slight increase compared to the second quarter of 2013 (-2 percent organic, +1 percent acquisition and +1 percent foreign currency translation).
  • Operating margin of 24.6 percent represented a 30 basis point decrease compared with the second quarter of 2013 primarily due to acquisition related charges.

Health & Science Technologies

  • Sales in the second quarter of $186 million reflected a 3 percent increase compared to the second quarter of 2013 (+1 percent organic and +2 percent foreign currency translation).
  • Operating margin of 19.5 percent represented a 40 basis point increase compared with the second quarter of 2013 primarily due to higher volume and productivity initiatives.

Fire & Safety/Diversified Products

  • Sales in the second quarter of $136 million reflected a 19 percent increase compared to the second quarter of 2013 (+17 percent organic and +2 percent foreign currency translation).
  • Operating margin of 26.4 percent represented a 570 basis point increase compared with the second quarter of 2013 primarily due to volume leverage and productivity initiatives as well as a prior year charge associated with a facility disposal in 2013.

For the second quarter of 2014, Fluid & Metering Technologies contributed 41 percent of sales and 44 percent of operating income; Health & Science Technologies accounted for 34 percent of sales and 28 percent of operating income; and Fire & Safety/Diversified Products represented 25 percent of sales and 28 percent of operating income.

EBITDA and Free Cash Flow

EBITDA means earnings before interest, income taxes, depreciation and amortization, while free cash flow means cash flow from operating activities less capital expenditures plus the excess tax benefit from stock-based compensation. Management uses these non-GAAP financial measures as internal operating metrics and for enterprise valuation purposes. Management believes these measures are useful as analytical indicators of leverage capacity and debt servicing ability, and uses them to measure financial performance as well as for planning purposes. However, they should not be considered as alternatives to net income, cash flow from operating activities or any other items calculated in accordance with U.S. GAAP, or as an indicator of operating performance. The definitions of EBITDA and free cash flow used here may differ from those used by other companies.

EBITDA and Free Cash Flow Bridge (dollars in millions)

         
For the Quarter Ended
June 30, March 31,
2014 2013 Change 2014 Change
Income before Taxes $ 101.5 $ 88.4 15 % $ 104.2 (3 %)
Depreciation and Amortization 19.4 20.1 (3 %) 19.3 1 %
Interest Expense   10.4     10.6   (2 %)   10.5   (1 %)
EBITDA $ 131.3   $ 119.1   10 % $ 134.0   (2 %)
 
Cash Flow from Operating Activities $ 92.0 $ 109.3 (16 %) $ 74.2 24 %
Capital Expenditures (12.5 ) (8.2 ) 52 % (10.8 ) 16 %
Excess Tax Benefit from Stock-Based Compensation   0.8     2.3   (65 %)   2.9   (72 %)
Free Cash Flow $ 80.3   $ 103.4   (22 %) $ 66.3   21 %
 

Conference Call to be Broadcast over the Internet

IDEX will broadcast its second quarter earnings conference call over the Internet on Wednesday, July 23, 2014 at 9:30 a.m. CT. Chairman and Chief Executive Officer Andy Silvernail and Senior Vice President and Chief Financial Officer Heath Mitts will discuss the Company’s recent financial performance and respond to questions from the financial analyst community. IDEX invites interested investors to listen to the call and view the accompanying slide presentation, which will be carried live on its website at www.idexcorp.com. Those who wish to participate should log on several minutes before the discussion begins. After clicking on the presentation icon, investors should follow the instructions to ensure their systems are set up to hear the event and view the presentation slides, or download the correct applications at no charge. Investors will also be able to hear a replay of the call by dialing 877.660.6853 (or 201.612.7415 for international participants) using the ID # 13583593.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act of 1934, as amended. These statements may relate to, among other things, capital expenditures, cost reductions, cash flow, and operating improvements and are indicated by words or phrases such as “anticipate,” “estimate,” “plans,” “expects,” “projects,” “should,” “will,” “management believes,” “the company believes,” “the company intends,” and similar words or phrases. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this news release. The risks and uncertainties include, but are not limited to, the following: economic and political consequences resulting from terrorist attacks and wars; levels of industrial activity and economic conditions in the U.S. and other countries around the world; pricing pressures and other competitive factors, and levels of capital spending in certain industries – all of which could have a material impact on order rates and IDEX’s results, particularly in light of the low levels of order backlogs it typically maintains; its ability to make acquisitions and to integrate and operate acquired businesses on a profitable basis; the relationship of the U.S. dollar to other currencies and its impact on pricing and cost competitiveness; political and economic conditions in foreign countries in which the company operates; interest rates; capacity utilization and the effect this has on costs; labor markets; market conditions and material costs; and developments with respect to contingencies, such as litigation and environmental matters. The forward-looking statements included here are only made as of the date of this news release, and management undertakes no obligation to publicly update them to reflect subsequent events or circumstances. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented here.

About IDEX

IDEX Corporation is an applied solutions company specializing in fluid and metering technologies, health and science technologies, and fire, safety and other diversified products built to its customers’ exacting specifications. Its products are sold in niche markets to a wide range of industries throughout the world. IDEX shares are traded on the New York Stock Exchange and Chicago Stock Exchange under the symbol “IEX”.

For further information on IDEX Corporation and its business units, visit the company’s website at www.idexcorp.com.

(Tables follow)

   
IDEX CORPORATION
Condensed Statements of Consolidated Operations
(in thousands except per share amounts)
(unaudited)
 
 
Three Months Ended Six Months Ended
June 30, June 30,
    2014   2013   2014   2013
 
Net sales $ 546,693 $ 518,445 $ 1,090,689 $ 1,012,893
Cost of sales     305,561     295,596     605,137       578,047  
Gross profit 241,132 222,849 485,552 434,846
Selling, general and administrative expenses     129,044     123,290     259,629       240,575  
Operating income 112,088 99,559 225,923 194,271
Other (income) expense - net 137 573 (707 ) (706 )
Interest expense     10,405     10,597     20,862       21,154  
Income before income taxes 101,546 88,389 205,768 173,823
Provision for income taxes     29,769     25,828     59,443       49,962  
Net income   $ 71,777   $ 62,561   $ 146,325     $ 123,861  
 
 
Earnings per Common Share:
Basic earnings per common share (a) $ 0.89 $ 0.76 $ 1.81 $ 1.50
Diluted earnings per common share (a) $ 0.88 $ 0.76 $ 1.79 $ 1.49
 
 
Share Data:
 
Basic weighted average common shares outstanding 80,106 81,829 80,317 82,013
 
Diluted weighted average common shares outstanding 81,149 82,734 81,362 82,943
 
 
Condensed Consolidated Balance Sheets
(in thousands)
(unaudited)
June 30, December 31,
            2014   2013
 
Assets
Current assets
Cash and cash equivalents $ 485,335 $ 439,629
Receivables - net 272,151 253,226
Inventories 254,182 230,967
Other current assets     69,858       67,131  
Total current assets 1,081,526 990,953
Property, plant and equipment - net 223,395 213,488
Goodwill and intangible assets 1,664,028 1,660,683
Other noncurrent assets     22,048       22,453  
Total assets   $ 2,990,997     $ 2,887,577  
 
Liabilities and shareholders' equity
Current liabilities
Trade accounts payable $ 146,827 $ 133,312
Accrued expenses 142,493 150,751
Short-term borrowings 111,539 1,871
Dividends payable     22,516       18,675  
Total current liabilities 423,375 304,609
Long-term borrowings 705,326 772,005
Other noncurrent liabilities     237,409       237,974  
Total liabilities 1,366,110 1,314,588
Shareholders' equity     1,624,887       1,572,989  
Total liabilities and shareholders' equity   $ 2,990,997     $ 2,887,577  
       
IDEX CORPORATION
Company and Business Group Financial Information
(dollars in thousands)
(unaudited)
 
 
Three Months Ended Six Months Ended
June 30, (b) June 30, (b)
    2014     2013     2014     2013  
 
 
Fluid & Metering Technologies
Net sales $ 226,100 $ 225,488 $ 449,461 $ 437,243
Operating income (c) 55,623 56,115 112,030 104,194
Operating margin 24.6 % 24.9 % 24.9 % 23.8 %
Depreciation and amortization $ 6,746 $ 7,012 $ 13,298 $ 13,972
Capital expenditures 3,554 2,507 7,563 5,283
 
Health & Science Technologies
Net sales $ 185,672 $ 180,867 $ 372,047 $ 353,735
Operating income (c) 36,137 34,522 72,366 66,789
Operating margin 19.5 % 19.1 % 19.5 % 18.9 %
Depreciation and amortization $ 10,690 $ 10,947 $ 21,399 $ 21,739
Capital expenditures 5,318 4,168 8,827 6,954
 
Fire & Safety/Diversified Products
Net sales $ 136,182 $ 114,236 $ 273,466 $ 225,749
Operating income (c) 35,985 23,676 75,633 51,908
Operating margin 26.4 % 20.7 % 27.7 % 23.0 %
Depreciation and amortization $ 1,672 $ 1,741 $ 3,352 $ 3,449
Capital expenditures 2,692 741 4,499 2,221
 
Company
Net sales $ 546,693 $ 518,445 $ 1,090,689 $ 1,012,893
Operating income 112,088 99,559 225,923 194,271
Operating margin 20.5 % 19.2 % 20.7 % 19.2 %
Depreciation and amortization (d) $ 19,416 $ 20,077 $ 38,673 $ 39,916
Capital expenditures 12,490 8,197 23,299 15,822
 
                         
 
(a) Calculated by applying the two-class method of allocating earnings to common stock and participating securities as required by ASC 260, Earnings Per Share.
 
(b) Three and six month data includes acquisitions of Aegis (April 2014) in the Fluid & Metering Technologies segment and FTL (March 2013) in the Health & Science Technologies segment from the date of acquisition.
 
(c) Segment operating income excludes unallocated corporate operating expenses.
 
(d) Depreciation and amortization excludes amortization of debt issuance expenses.

Contacts

IDEX Corporation
Investor Contact:
Heath Mitts
Senior Vice President and Chief Financial Officer
(847) 498-7070

Sharing

Contacts

IDEX Corporation
Investor Contact:
Heath Mitts
Senior Vice President and Chief Financial Officer
(847) 498-7070